ANGO vs LLY · rev $292.5M vs P/E 39, rev $65.18B
AngioDynamics Inc (ANGO) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ANGO currently screens at market cap $378.5M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ANGO and LLY stock pages for the full models.
Not investment advice.